In a filing, Verona Pharma Plc ADR revealed its Chief Financial Officer Hahn Mark W unloaded Company’s shares for reported $0.49 million on Nov 29 ’24. In the deal valued at $5.01 per share,98,704 shares were sold. As a result of this transaction, Hahn Mark W now holds 14,177,296 shares worth roughly $554.47 million.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Then, Hahn Mark W sold 12,936 shares, generating $64,680 in total proceeds. Upon selling the shares at $5.00, the Chief Financial Officer now owns 14,276,000 shares.
Before that, Hahn Mark W sold 1,600 shares. Verona Pharma Plc ADR shares valued at $8,000 were divested by the Chief Financial Officer at a price of $5.00 per share. As a result of the transaction, Hahn Mark W now holds 14,175,696 shares, worth roughly $554.41 million.
Wells Fargo initiated its Verona Pharma Plc ADR [VRNA] rating to an Overweight in a research note published on October 03, 2024; the price target was $50. Piper Sandler started covering the stock on August 26, 2022. It rated VRNA as “an Overweight”.
Price Performance Review of VRNA
On Monday, Verona Pharma Plc ADR [NASDAQ:VRNA] saw its stock fall -1.31% to $39.11. Over the last five days, the stock has gained 0.77%. Verona Pharma Plc ADR shares have risen nearly 96.73% since the year began. Nevertheless, the stocks have risen 189.28% over the past one year. While a 52-week high of $40.76 was reached on 11/29/24, a 52-week low of $11.39 was recorded on 05/30/24. SMA at 50 days reached $34.64, while 200 days put it at $22.67.
Levels Of Support And Resistance For VRNA Stock
The 24-hour chart illustrates a support level at 38.54, which if violated will result in even more drops to 37.98. On the upside, there is a resistance level at 40.05. A further resistance level may holdings at 41.00. The Relative Strength Index (RSI) on the 14-day chart is 59.52, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 1.43, which suggests price will go up in the next trading period. Percent R suggests that price movement has been bullish at 26.34%. Stochastics %K at 83.86% indicates the stock is a selling.
How much short interest is there in Verona Pharma Plc ADR?
A steep rise in short interest was recorded in Verona Pharma Plc ADR stocks on 2024-11-15, dropping by -1.97 million shares to a total of 5.98 million shares. Yahoo Finance data shows the prior-month short interest on 2024-10-15 was 7.94 million shares. There was a decline of -32.9%, which implies that there is a negative sentiment for the stock.
The most recent change occurred on September 13, 2021 when H.C. Wainwright began covering the stock and recommended ‘”a Buy”‘ rating along with a $25 price target.
